Understanding how the coronavirus replicates its RNA
Coronavirus RNA synthesis by multicomponent protein machines
['FUNDING_R01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10669608
This study is looking at how the SARS-CoV-2 virus makes copies of itself, which is important for understanding how it spreads, and it's aimed at finding new ways to treat COVID-19 more effectively.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10669608 on ClinicalTrials.gov |
What this research studies
This research investigates the complex machinery that the SARS-CoV-2 virus uses to replicate its RNA, which is crucial for its survival and spread. By examining how various protein components work together in this replication process, the study aims to identify potential new antiviral targets and improve existing treatments. The research employs a range of advanced techniques, including biochemistry, biophysics, and cryo-electron microscopy, to gain insights into the virus's replication mechanisms. This could lead to the development of more effective antiviral therapies for COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by COVID-19 or those at high risk of severe illness from the virus.
Not a fit: Patients who are not infected with SARS-CoV-2 or who do not have risk factors for COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new antiviral drugs that more effectively combat COVID-19.
How similar studies have performed: Previous research on antiviral mechanisms targeting viral replication has shown promise, indicating that this approach could yield significant advancements.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIRCHDOERFER, ROBERT N — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: KIRCHDOERFER, ROBERT N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.